Hogan Lovells US LLP

Intellectual Property

Partner

Daniel Brook is a patent litigator in the United Kingdom. He acts for clients such as Merck Sharp & Dohme, Lilly, Amgen and Bristol Myers Squibb. Recent key cases include Actavis v. Lilly (Supreme Court), Schutz v. Werit (Supreme Court), and BMS v. Teva (availability of interim injunctions). He has experience with each of the major patent jurisdictions in Europe. He regularly manages cross border patent litigation for clients on their most important products and has been involved in a number of leading cases.

English

AIPPI Council Member, CIPA, EPLAW

M.A. Natural Sciences - Chemistry, University of Cambridge, 1999

M.Sci, University of Cambridge, 1999